CORC

在结果中检索

CORC

浏览/检索结果: 共133条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer 期刊论文
2019
作者:  Ma Fei;  Guan Yanfang;  Yi Zongbi;  Chang Lianpeng;  Li Qiao
收藏  |  浏览/下载：19/0  |  提交时间：2020/01/03
Pyrotinib or Lapatinib Combined With Capecitabine in HER2-Positive Metastatic Breast Cancer With Prior Taxanes, Anthracyclines, and/or Trastuzumab: A Randomized, Phase II Study 期刊论文
2019, 卷号: 37, 期号: 29, 页码: 2610-2619
作者:  Ma Fei;  Ouyang Quchang;  Li Wei;  Jiang Zefei;  Tong Zhongsheng
收藏  |  浏览/下载：32/0  |  提交时间：2020/01/03
Neratinib-based therapy in patients with metastatic HER2-positive breast cancer from Asia 期刊论文
2019
作者:  Xu Binghe;  Kim Sung-Bae;  Inoue Kenichi;  Lee JuRueyJiuan;  Zhang Bo
收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03
Trastuzumab treatment after progression in HER2-positive metastatic breast cancer following relapse of trastuzumab-based regimens: a meta-analysis 期刊论文
2019, 卷号: 11, 页码: 4699-4706
作者:  Han, Yiqun;  Wang, Jiayu;  Liu, Weiming;  Yuan, Peng;  Li, Qing
收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03
Patient-reported outcomes in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer receiving olaparib versus chemotherapy in the OlympiAD trial 期刊论文
2019, 卷号: 120, 页码: 20-30
作者:  Robson Mark;  Ruddy Kathryn J;  Im Seock-Ah;  Senkus Elżbieta;  Xu Binghe
收藏  |  浏览/下载：21/0  |  提交时间：2020/01/03
Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients: A Phase I Clinical Trial 期刊论文
2019, 卷号: 25, 期号: 17, 页码: 5212-5220
作者:  Li Qiao;  Guan Xiuwen;  Chen Shanshan;  Yi Zongbi;  Lan Bo
收藏  |  浏览/下载：6/0  |  提交时间：2020/01/03
Everolimus in hormone receptor-positive metastatic breast cancer: PIK3CA mutation H1047R was a potential efficacy biomarker in a retrospective study 期刊论文
2019, 卷号: 19, 期号: 1, 页码: 442
作者:  Yi, Zongbi;  Ma, Fei;  Liu, Binliang;  Guan, Xiuwen;  Li, Lixi
收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03
Apatinib combined with chemotherapy in patients with previously treated advanced breast cancer: An observational study 期刊论文
2019, 卷号: 17, 期号: 6, 页码: 4768-4778
作者:  Zhu, Anjie;  Yuan, Peng;  Wang, Jiayu;  Fan, Ying;  Luo, Yang
收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03
Bispecific CD3-HAC carried by E1A-engineered mesenchymal stromal cells against metastatic breast cancer by blocking PD-L1 and activating T cells 期刊论文
2019, 卷号: 12, 期号: 1, 页码: 46
作者:  Yang, Yuanyuan;  Zhang, Xiaolong;  Lin, Fangzhen;  Xiong, Mengshang;  Fan, Dongmei
收藏  |  浏览/下载：8/0  |  提交时间：2020/01/03
The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer 期刊论文
2019, 卷号: 39, 期号: 1, 页码: 1
作者:  Guan, Xiuwen;  Ma, Fei;  Li, Chunxiao;  Wu, Shiyang;  Hu, Shangying
收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03

©版权所有 ©2017 CSpace - Powered by CSpace